In this comprehensive online program led by expert faculty, learn about implementation of rapid ART in newly diagnosed people with HIV, choosing an individualized first-line regimen for each patient, factors to consider when modifying therapy in virologically suppressed individuals or in patients with virologic failure, and evaluating patients for PrEP. Watch the Medical Minute videos and have your questions answered by faculty during the live webinars. Download the slides and patient education resources, listen to podcasts, and read the companion ClinicalThought commentaries.
In this case example, learn data and recommendations for considering a switch to long-acting CAB plus RPV, including current indications and contraindications, data for “direct to inject” without an oral lead-in, and considerations for dosing every 8 weeks vs every 4 weeks.
In this case example, learn data and recommendations for considering an ART switch following weight gain, including what is known about ART-associated weight gain and resulting metabolic complications, what the data are for switching, and what the guidelines recommend in this scenario.